SCHEMBL2329962

SCHEMBL2329962

O=C1Nc2ccc(O)c(I)c21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.37
CES1 P23141 4/20 0.37
TGM2 P21980 2/20 0.37
CCNE2 O96020 1/20 0.35
CCNE1 P24864 1/20 0.35
CDK2 P24941 1/20 0.35
CYP1A2 P05177 2/20 0.33
LRRK2 Q5S007 2/20 0.33
AURKA O14965 1/20 0.33
CYP1A1 P04798 1/20 0.33
CDC25B P30305 1/20 0.33
TXNRD1 Q16881 1/20 0.33
TXNRD3 Q86VQ6 1/20 0.33
COPS5 Q92905 1/20 0.33
AURKB Q96GD4 1/20 0.33
TXNRD2 Q9NNW7 1/20 0.33
CHEK1 O14757 3/20 0.33
PLK4 O00444 2/20 0.33
EGFR P00533 2/20 0.33
PRKCA P17252 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30741210 0.71 CES1 (0.50) CES1TGM2RAF1CSNK2A1MEN1
SCHEMBL2059124 0.71 CES1 (0.50) CES1TGM2RAF1CSNK2A1MEN1
SCHEMBL2331366 0.70 PDPK1 (0.54) PDPK1CES1TGM2LRRK2AURKA
SCHEMBL2292542 0.69 TXNRD1 (0.50) CYP1A2AURKACYP1A1CDC25BTXNRD1
SCHEMBL5738366 0.68 CES1 (0.67) CES1TGM2LRRK2CHEK1MEN1
SCHEMBL13424915 0.67 AURKA (0.44) AURKANTRK1MEN1HPGDAPEX1
SCHEMBL7795435 0.65 TDP2 (0.53) PDPK1CES1TGM2CDK2LRRK2
SCHEMBL361051 0.65 PIM1 (0.41) CDK2CYP1A2AURKACYP1A1CDC25B
SCHEMBL6917819 0.60 PDPK1 (0.49) PDPK1CES1TGM2LRRK2AURKA
SCHEMBL3581495 0.60 KDM4E (0.50) CHEK1EGFRPRKCARAF1CSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2355825-A2 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS Schering Corporation (US) 2011-08-17 EP disclosed
WO-2010054278-A2 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2010-05-14 WO disclosed